Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $357,249 - $664,016
-2,825 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $637,941 - $1.04 Million
2,825 New
2,825 $717,000
Q3 2021

Nov 09, 2021

SELL
$221.9 - $484.47 $650,832 - $1.42 Million
-2,933 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $381,026 - $689,196
2,933 New
2,933 $689,000
Q1 2021

May 06, 2021

SELL
$109.18 - $185.98 $294,786 - $502,146
-2,700 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $177,498 - $458,622
2,700 New
2,700 $282,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Q Pula Trading Management LP Portfolio

Follow Q Pula Trading Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Q Pula Trading Management LP with notifications on news.